Medison Biotech: Jonathan Goodman Takes Advantage of His Own Failure to Create Value, Enriching Himself at the Expense of the Shareholders of Knight Therapeutics

WVNews | Business

Jul 9, 2019

PETACH TIKVA, Israel--(BUSINESS WIRE)--Jul 9, 2019--